Market closedNon-fractional
Cellebrite/CLBT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Cellebrite
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
Ticker
CLBT
Sector
Technology
Trading on
NASDAQ
Industry
Software
Headquarters
Petah Tikva, Israel
Employees
1,008
Website
www.cellebrite.com
Cellebrite Metrics
BasicAdvanced
$2.8B
Market cap
-
P/E ratio
-$0.59
EPS
1.51
Beta
-
Dividend rate
Price and volume
Market cap
$2.8B
Beta
1.51
Financial strength
Current ratio
1.611
Quick ratio
1.441
Long term debt to equity
-30.368
Total debt to equity
-48.487
Interest coverage (TTM)
1.06%
Management effectiveness
Return on assets (TTM)
5.58%
Return on equity (TTM)
-1,768.51%
Valuation
Price to revenue (TTM)
8.021
Price to book
-101.09
Price to tangible book (TTM)
-42.22
Price to free cash flow (TTM)
29.135
Growth
Revenue change (TTM)
16.53%
Earnings per share change (TTM)
-640.21%
3-year revenue growth (CAGR)
16.27%
3-year earnings per share growth (CAGR)
270.01%
What the Analysts think about Cellebrite
Analyst Ratings
Majority rating from 8 analysts.
Cellebrite Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$90M
-3.76%
Net income
-$71M
388.36%
Profit margin
-79.66%
407.71%
Cellebrite Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.05
$0.10
$0.11
$0.08
-
Expected
$0.02
$0.05
$0.06
$0.06
$0.05
Surprise
114.29%
118.95%
89.66%
45.45%
-
Cellebrite News
AllArticlesVideos
Cellebrite Advances Plans to Transform and Elevate its Strategic Relationship with the U.S. Federal Government
GlobeNewsWire·1 week ago
Cellebrite: Very Strong Competitive Advantage That Is Hard To Replicate
Seeking Alpha·2 weeks ago
Cellebrite to Report Second-Quarter 2024 Financial Results on August 15, 2024
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cellebrite stock?
Cellebrite (CLBT) has a market cap of $2.8B as of July 27, 2024.
What is the P/E ratio for Cellebrite stock?
The price to earnings (P/E) ratio for Cellebrite (CLBT) stock is 0 as of July 27, 2024.
Does Cellebrite stock pay dividends?
No, Cellebrite (CLBT) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Cellebrite dividend payment date?
Cellebrite (CLBT) stock does not pay dividends to its shareholders.
What is the beta indicator for Cellebrite?
Cellebrite (CLBT) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Cellebrite stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.